Neurocritical Care

, Volume 14, Issue 2, pp 200–207

Association of CSF Biomarkers and Secondary Insults Following Severe Traumatic Brain Injury

  • Deborah M. Stein
  • Joseph A. Kufera
  • Allison Lindell
  • Karen R. Murdock
  • Jay Menaker
  • Grant V. Bochicchio
  • Bizhan Aarabi
  • Thomas M. Scalea
Original Article

Abstract

Background

Management of severe traumatic brain injury (TBI) focuses on mitigating secondary insults. There are a number of biomarkers that are thought to play a part in secondary injury following severe TBI. Two of these, S100β and neuron-specific enolase (NSE), have been extensively studied in the setting of neurological injury. This pilot study was undertaken to investigate the relationship of S100β and NSE to clinical markers of severity and poor outcome: intracranial hypertension (ICH), and cerebral hypoperfusion (CH).

Methods

Patients at the R Adams Cowley Shock Trauma Center were prospectively enrolled over an 18-month period. Inclusion criteria were: age > 18, admission within the first 6 h after injury, Glasgow Coma Scale (GCS) < 9 on admission, isolated TBI, and placement of an intraventricular catheter (IVC). Patients were managed according to an institutional protocol based on the Brain Trauma Foundation Guidelines. CSF was collected from the IVC on admission and twice daily for 7 days. S100β and NSE levels were analyzed by ELISA. CSF levels drawn before (PRE) and after (POST) 12-h time periods were compared to percentage time intracranial pressure (ICP) > 20 mmHg (% ICP20) and cerebral perfusion pressure (CPP) < 60 mmHg (% CPP60), and cumulative “Pressure times Time Dose” (PTD) for episodes of ICP > 20 mmHg (PTD ICP20) and CPP < 60 mmHg (PTD CPP60). Statistical analysis was performed using the Student’s t test to compare means and non-parametric Wilcoxon statistic to compare ranked data. Linear regression methods were applied to compare levels of S100β and NSE with ICP and CPP.

Results

Twenty-three patients were enrolled. The cohort of patients was severely injured and neurologically compromised on admission (admission GCS = 5.6 ± 3.1, Injury Severity Score (ISS) = 31.9 ± 10.6, head Abbreviated Injury Scale (AIS) = 4.4 ± 0.7, Marshall score = 2.6 ± 0.9). Elevated levels of S100β and NSE were found in all 223 CSF samples analyzed. ICH was found to be associated with PRE and POST S100β levels when measured as % ICP20 (r = 0.20 and r = 0.23, P < 0.01) and PTD ICP20 (r = 0.35 and r = 0.26, P < 0.001). POST increasing NSE levels were weakly correlated with increasing PTD ICP20 (r = 0.17, P = 0.01). PRE S100β levels were associated with episodes of CH as measured by % CPP60 (r = 0.20, P = 0.002) and both PRE and POST S100β levels were associated with PTD CPP60 (r = 0.24 and r = 0.23, P < 0.001). PRE and POST NSE levels were also associated with episodes of CH as measured by % CPP60 (r = 0.22 and r = 0.18, P < 0.01) and PTD CPP60 (r = 0.20 and r = 0.21, P < 0.01).

Conclusions

In this preliminary analysis, S100β levels were associated with ICH and CH over a full week of ICP monitoring. We also found associations between CH and NSE levels in CSF of patients with severe TBI. Our results suggest that there is an association between levels of ICH and CH and these biomarkers when measured before episodes of clinically significant secondary insults. These markers of neuronal cell death demonstrate promise as both indicators of impending clinical deterioration and targets of future therapeutic interventions.

Keywords

Traumatic brain injury Biomarkers Cerebral perfusion pressure Intracranial pressure Secondary insults 

References

  1. 1.
    Langlois J, Rutland-Brown W, Wald M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21(5):375–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Kraus JF, MacArthur DL. Epidemiology of brain injury. In: Evans RW, editor. Neurology and Trauma. New York, NY: Oxford University Press; 2006. p. 3–18.Google Scholar
  3. 3.
    Ghajar J. Traumatic brain injury. Lancet. 2000;356:923–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Thurman D, Alverson C, Dunn K, Guerrero J, Sniezek J. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14(6):602–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Kennedy CS, Moffatt M. Acute traumatic brain injury in children: exploring the cutting edge in understanding, therapy, and research. Clin Pediatr Emerg Med. 2004;5(4):224–38.CrossRefGoogle Scholar
  6. 6.
    Vos PE, Lamers KJB, Hendriks JCM, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62(8):1303–10.PubMedGoogle Scholar
  7. 7.
    Miller JD, Sweet RC, Narayan R, et al. Early insults to the injured brain. JAMA. 1978;240:432–9.Google Scholar
  8. 8.
    Signorini DF, Andrews PJ, Jones PA, et al. Adding insult to injury: the prognostic value of early secondary insults to survival after traumatic brain injury. J Neurol Neurosurg Psychiatry. 1999;66:26–31.PubMedCrossRefGoogle Scholar
  9. 9.
    Chambers IR, Treadwell L, Mendelow AD. The cause and incidence of secondary insults in severely head-injured adults and children. Br J Neurosurg. 2000;14:424–31.PubMedCrossRefGoogle Scholar
  10. 10.
    Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(Suppl 1):S37–44.PubMedGoogle Scholar
  11. 11.
    Chestnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34:216–22.CrossRefGoogle Scholar
  12. 12.
    Stocchetti N, Furlan A, Volta F. Hypoxemia and arterial hypotension at the accident scene in head injury. J Trauma. 1996;40(5):764–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Eisenberg H, Frankowski R, Contant C, et al. High dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg. 1988;69:15–23.PubMedCrossRefGoogle Scholar
  14. 14.
    Narayan R, Kishore P, Becker D, et al. Intracranial pressure: to monitor or not to monitor? A review of our experience with head injury. J Neurosurg. 1982;56:650–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Schreiber MA, Aoki N, Scott B, et al. Determination of mortality in patients with severe blunt head injury. Arch Surg. 2002;137:285–90.PubMedCrossRefGoogle Scholar
  16. 16.
    Changaris DG, McGraw CP, Richardson JD, et al. Correlation of cerebral perfusion pressure and Glasgow Coma Scale to outcome. J Trauma. 1987;27:1007–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med. 1999;27:2086–95.PubMedCrossRefGoogle Scholar
  18. 18.
    Zimmer DB, Cornwall EH, Landar A, et al. The S100 protein family: history, function, and expression. Brain Res Bull. 1995;37:417–29.PubMedCrossRefGoogle Scholar
  19. 19.
    Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci. 1987;10:269–95.PubMedCrossRefGoogle Scholar
  20. 20.
    Vos PE, Lamers KJB, Hendriks JCM, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62:1303–10.PubMedGoogle Scholar
  21. 21.
    Nguyen DN, Spapen H, Su F, et al. Elevated serum levels of S-100β protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med. 2006;34(7):1967–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Pelinka L, Kroepfl A, Leixnering M, et al. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma. 2004;21(11):1553–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Pleines U, Moragnti-Kossman C, Rancan M, et al. S-100B reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18(5):491–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Spinella PC, Dominguez T, Drott HR, et al. S-100B protein-serum levels in healthy children and its association with outcome in pediatric traumatic brain injury. Crit Care Med. 2003;31(3):939–45.PubMedCrossRefGoogle Scholar
  25. 25.
    Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock. 2004;22(2):102–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Berger RP, Pierce MC, Wisniewski SR, et al. Neuron specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics. 2002;109(2):E31.PubMedCrossRefGoogle Scholar
  27. 27.
    Kirchhoff C, Buhmann S, Braunstein V, et al. Cerebrospinal S100-B: a potential marker for progressive intracranial hemorrhage in patients with severe traumatic brain injury. Eur J Med Res. 2008;13(11):511–6.PubMedGoogle Scholar
  28. 28.
    Association for the advancement of automotive medicine. Abbreviated Injury Scale, 2005. Barrington, IL: AAAM; 2005.Google Scholar
  29. 29.
    Boyd CR, Tolson MA, Copes WS. Evaluating trauma care: the TRISS method. Trauma score and the injury severity score. J Trauma. 1987;27:370–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Marshall LF, Bowers-Marshall S, Klauber MR, et al. A new classification of head injury based on computerized tomography. J Neurosurg. 1991;75(Suppl):S14–20.Google Scholar
  31. 31.
    Wilson JTL, Pettigrew LEL, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15(8):573–85.PubMedCrossRefGoogle Scholar
  32. 32.
    Joseph DK, Dutton RP, Aarabi B, Scalea TM. Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma. 2004;57(4):687–93. (discussion 693–695).PubMedCrossRefGoogle Scholar
  33. 33.
    Scalea TM, Bochicchio GV, Habashi N, McCunn M, Shih D, McQuillan K, Aarabi B. Increased intra-abdominal, intrathoracic, and intracranial pressure after severe brain injury: multiple compartment syndrome. J Trauma. 2007;62(3):647–56. (discussion 656).PubMedCrossRefGoogle Scholar
  34. 34.
    Kahraman S, Hu P, Xiao Y, Dutton RP, Aarabi B, Stein DM, Scalea TM. Pressure-time dose of automated ICP and CPP data predicts outcomes in severe TBI. J Trauma. 2010;69:110–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Vik A, Nag T, Fredriksli OA, et al. Relationship of “dose” of intracranial hypertension to outcome in severe traumatic brain injury. J Neurosurg. 2008;109:678–84.PubMedCrossRefGoogle Scholar
  36. 36.
    Kramer M. R2 statistics for mixed models. Stat Med. 2008;27(29):6137–57.CrossRefGoogle Scholar
  37. 37.
    Xu R. Measuring explained variation in linear mixed effects models. Stat Med. 2003;22:3527–41.PubMedCrossRefGoogle Scholar
  38. 38.
    Fano G, Biocca S, Fulle S, et al. The S-100 protein family in search of a function. Prog Neurobiol. 1995;46:71–82.PubMedCrossRefGoogle Scholar
  39. 39.
    McAdory BS, van Eldik LJ, Norden JJ. S-100B, a neurotrophic protein that modulates neuronal protein phosphorylation, is upregulated during lesion induced collateral sprouting and reactive synaptogenesis. Brain Res. 1998;813:211–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33:637–68.PubMedCrossRefGoogle Scholar
  41. 41.
    Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum; markers of cell damage in human central nervous system. Stroke. 1987;18:911–8.PubMedGoogle Scholar
  42. 42.
    Bridges E, Biever K. Joint combat casualty research team and joint theater trauma system. AACN Adv Critical Care. 2010;21:260–76.CrossRefGoogle Scholar
  43. 43.
    Goodman MD, Makley AT, Lentsch AB, et al. Traumatic brain injury and aeromedical evacuation: when is the brain fit to fly? J Surg Res. 2010;164:286–93.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Deborah M. Stein
    • 1
    • 2
  • Joseph A. Kufera
    • 2
  • Allison Lindell
    • 2
  • Karen R. Murdock
    • 2
  • Jay Menaker
    • 1
    • 2
  • Grant V. Bochicchio
    • 1
    • 2
  • Bizhan Aarabi
    • 1
  • Thomas M. Scalea
    • 1
    • 2
  1. 1.Division of Critical Care/Program in Trauma, R Adams Cowley Shock Trauma CenterUniversity of Maryland School of MedicineBaltimoreUSA
  2. 2.The Shock, Trauma and Anesthesiology Research Organized Research CenterUniversity of Maryland School of MedicineBaltimoreUSA

Personalised recommendations